Market Research Industry Reports

Horizon Pharma Plc (HZNP) - Financial and Strategic SWOT Analysis Review

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Horizon Pharma Plc (HZNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Horizon Pharma plc (Horizon Pharma) is a pharmaceutical company which develops and commercializes medical products for the treatment of pain, arthritis and inflammatory diseases. It markets medicines through its orphan, primary care and rheumatology business units. The companys marketed products include Actimmune, Buphenyl, Duexis, Krystexxa, Migergot, Pennsaid 2%, Procysbi, Quinsair, Ravicti, Rayos and Vimovo. Horizon Pharma provides products and services to patients and healthcare professionals in the US. The company operates through offices in Illinois, California, Switzerland, the Netherlands and Germany. Horizon Pharma is headquartered in Dublin, Ireland.

Horizon Pharma Plc Key Recent Developments

Jun 04,2018: Horizon Pharma and the National Organization for Rare Disorders (NORD) Illustrate 35 years of Progress in Rare Disease at the Biotechnology Innovation Organization (BIO) International Convention
May 22,2018: Horizon Pharma Named One of the Best Small and Medium Workplaces in Chicago by FORTUNE
May 09,2018: Horizon Pharma Reports Strong First-Quarter 2018 Orphan and Rheumatology Net Sales Growth
Feb 28,2018: Horizon Pharma Announces Fourth-Quarter and Full-Year 2017 Results
Jan 08,2018: Horizon Pharma Increases Peak Net Sales Guidance for Key Growth Drivers and Announces Rheumatology and Orphan Pipeline Developments

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Horizon Pharma Plc - Key Facts 6
Horizon Pharma Plc - Key Employees 7
Horizon Pharma Plc - Key Employee Biographies 8
Horizon Pharma Plc - Major Products and Services 10
Horizon Pharma Plc - History 11
Horizon Pharma Plc - Company Statement 15
Horizon Pharma Plc - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Section 2 Company Analysis 17
Horizon Pharma Plc - Business Description 17
Horizon Pharma Plc - SWOT Analysis 18
SWOT Analysis - Overview 18
Horizon Pharma Plc - Strengths 18
Horizon Pharma Plc - Weaknesses 19
Horizon Pharma Plc - Opportunities 20
Horizon Pharma Plc - Threats 21
Horizon Pharma Plc - Key Competitors 22
Section 3 Company Financial Ratios 23
Financial Ratios - Capital Market Ratios 23
Financial Ratios - Annual Ratios 24
Performance Chart 27
Financial Performance 27
Financial Ratios - Interim Ratios 28
Financial Ratios - Ratio Charts 29
Section 4 Companys Lifesciences Financial Deals and Alliances 30
Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32
Horizon Pharma Plc, Recent Deals Summary 33
Section 5 Companys Recent Developments 34
Jun 04, 2018: Horizon Pharma and the National Organization for Rare Disorders (NORD) Illustrate 35 years of Progress in Rare Disease at the Biotechnology Innovation Organization (BIO) International Convention 34
May 22, 2018: Horizon Pharma Named One of the Best Small and Medium Workplaces in Chicago by FORTUNE 35
May 09, 2018: Horizon Pharma Reports Strong First-Quarter 2018 Orphan and Rheumatology Net Sales Growth 36
Feb 28, 2018: Horizon Pharma Announces Fourth-Quarter and Full-Year 2017 Results 39
Jan 08, 2018: Horizon Pharma Increases Peak Net Sales Guidance for Key Growth Drivers and Announces Rheumatology and Orphan Pipeline Developments 43
Nov 30, 2017: Horizon Pharma Names Shao-Lee Lin, M.D., Ph.D. Executive Vice President, Research and Development and Chief Scientific Officer 46
Nov 06, 2017: Horizon Pharma Announces Third-Quarter and Year-to-Date 2017 Results 47
Oct 26, 2017: Horizon Pharma to Leverage Medidata Clinical Cloud and eTMF Solutions to Support its Business Transformation 50
Oct 26, 2017: Horizon Pharma plc to Leverage Medidata Clinical Cloud and eTMF Solutions to Support its Business Transformation 51
Oct 17, 2017: Horizon Pharma Named One of the Best Small & Medium Workplaces by FORTUNE and Great Place to Work for the Second Year in a Row 52
Section 6 Appendix 53
Methodology 53
Ratio Definitions 53
About GlobalData 57
Contact Us 57
Disclaimer 57

List Of Tables

List of Tables
Horizon Pharma Plc, Key Facts 6
Horizon Pharma Plc, Key Employees 7
Horizon Pharma Plc, Key Employee Biographies 8
Horizon Pharma Plc, Major Products and Services 10
Horizon Pharma Plc, History 11
Horizon Pharma Plc, Subsidiaries 16
Horizon Pharma Plc, Key Competitors 22
Horizon Pharma Plc, Ratios based on current share price 23
Horizon Pharma Plc, Annual Ratios 24
Horizon Pharma Plc, Annual Ratios (Cont...1) 25
Horizon Pharma Plc, Annual Ratios (Cont...2) 26
Horizon Pharma Plc, Interim Ratios 28
Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32
Horizon Pharma Plc, Recent Deals Summary 33
Currency Codes 53
Capital Market Ratios 53
Equity Ratios 54
Profitability Ratios 54
Cost Ratios 55
Liquidity Ratios 55
Leverage Ratios 56
Efficiency Ratios 56

List Of Figures

List of Figures
Horizon Pharma Plc, Performance Chart (2013 - 2017) 27
Horizon Pharma Plc, Ratio Charts 29
Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 32

Horizon Healthcare Services Inc - Strategic SWOT Analysis Review

Horizon Healthcare Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,

USD 125View Report

India Multistage Water Pumps Market By Operation (Horizontal and Vertical), By End Use Industry (Power, Oil and Gas, etc), By Product Type (Ring Section, Split Casing, etc), By Application, By Sales Channel, Competition Forecast and Opportunities, 2013-2023

According to India Multistage Water Pumps Market By Operation, By End Use Industry, By Product Type, By Application, By Sales Channel, Competition Forecast & Opportunities, 2013-2023 multistage water pumps market

USD 2700View Report

N4 Pharma Plc (N4P) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

N4 Pharma Plc (N4 Pharma), formerly Onzima Ventures Plc is a pharmaceutical company that reformulates vaccines and drugs. The company provides generic products such as sartans, sildenafil, and aprepitant. It

USD 250View Report

Verona Pharma Plc (VRP) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 125
  • Site Licence    USD 250
  • Enterprise Wide Licence    USD 375
$ 125

Reports Details

Published Date : Jun 2018
No. of Pages :57
Country :Ireland
Category :Swot Analysis
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube